302 related articles for article (PubMed ID: 32421186)
1. Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.
Kunchok A; Aksamit AJ; Davis JM; Kantarci OH; Keegan BM; Pittock SJ; Weinshenker BG; McKeon A
JAMA Neurol; 2020 Aug; 77(8):937-946. PubMed ID: 32421186
[TBL] [Abstract][Full Text] [Related]
2. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Izadi Z; Brenner EJ; Mahil SK; Dand N; Yiu ZZN; Yates M; Ungaro RC; Zhang X; Agrawal M; Colombel JF; Gianfrancesco MA; Hyrich KL; Strangfeld A; Carmona L; Mateus EF; Lawson-Tovey S; Klingberg E; Cuomo G; Caprioli M; Cruz-Machado AR; Mazeda Pereira AC; Hasseli R; Pfeil A; Lorenz HM; Hoyer BF; Trupin L; Rush S; Katz P; Schmajuk G; Jacobsohn L; Seet AM; Al Emadi S; Wise L; Gilbert EL; Duarte-García A; Valenzuela-Almada MO; Isnardi CA; Quintana R; Soriano ER; Hsu TY; D'Silva KM; Sparks JA; Patel NJ; Xavier RM; Marques CDL; Kakehasi AM; Flipo RM; Claudepierre P; Cantagrel A; Goupille P; Wallace ZS; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Robinson PC; Machado PM; Griffiths CEM; Barker JN; Smith CH; Yazdany J; Kappelman MD; ;
JAMA Netw Open; 2021 Oct; 4(10):e2129639. PubMed ID: 34661663
[TBL] [Abstract][Full Text] [Related]
3. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases.
Langer-Gould A; Qian L; Tartof SY; Brara SM; Jacobsen SJ; Beaber BE; Sy LS; Chao C; Hechter R; Tseng HF
JAMA Neurol; 2014 Dec; 71(12):1506-13. PubMed ID: 25329096
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.
Atzeni F; Talotta R; Masala IF; Gerardi MC; Casale R; Sarzi-Puttini P
Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):500-510. PubMed ID: 31174819
[TBL] [Abstract][Full Text] [Related]
5. Absolute and Relative Risk of New-Onset Psoriasis Associated With Tumor Necrosis Factor-α Inhibitor Treatment in Patients With Immune-Mediated Inflammatory Diseases: A Danish Nationwide Cohort Study.
Thein D; Egeberg A; Skov L; Loft N
JAMA Dermatol; 2022 Sep; 158(9):997-1004. PubMed ID: 35767240
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy.
Cortese R; Prosperini L; Stasolla A; Haggiag S; Villani V; Simone IL; Gasperini C; Tortorella C
J Neurol; 2021 Aug; 268(8):2895-2899. PubMed ID: 33611609
[TBL] [Abstract][Full Text] [Related]
7. Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.
Zhou M; Xu R; Kaelber DC; Gurney ME
PLoS One; 2020; 15(3):e0229819. PubMed ID: 32203525
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases.
Etminan M; Sodhi M; Samii A; Carleton BC; Kezouh A; Antonio Avina-Zubieta J
Semin Arthritis Rheum; 2019 Jun; 48(6):1083-1086. PubMed ID: 30337056
[TBL] [Abstract][Full Text] [Related]
9. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Ertz-Archambault N; Kosiorek H; Taylor GE; Kelemen K; Dueck A; Castro J; Marino R; Gauthier S; Finn L; Sproat LZ; Palmer J; Mesa RA; Al-Kali A; Foran J; Tibes R
JAMA Oncol; 2017 Jul; 3(7):936-943. PubMed ID: 28152123
[TBL] [Abstract][Full Text] [Related]
10. Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study.
Wroński J; Fiedor P; Głuszko P
Int J Clin Pharm; 2019 Aug; 41(4):864-871. PubMed ID: 31172410
[TBL] [Abstract][Full Text] [Related]
11. Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study.
Singla S; Putman M; Liew J; Gordon K
Lancet Rheumatol; 2023 Apr; 5(4):e200-e207. PubMed ID: 38251522
[TBL] [Abstract][Full Text] [Related]
12. Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis.
Lee MP; Desai RJ; Jin Y; Brill G; Ogdie A; Kim SC
JAMA Dermatol; 2019 Jun; 155(6):700-707. PubMed ID: 30916734
[TBL] [Abstract][Full Text] [Related]
13. Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor.
Chey SY; Kermode AG
Mult Scler J Exp Transl Clin; 2022; 8(1):20552173211070750. PubMed ID: 35024163
[TBL] [Abstract][Full Text] [Related]
14. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Korzenik J; Larsen MD; Nielsen J; Kjeldsen J; Nørgård BM
Aliment Pharmacol Ther; 2019 Aug; 50(3):289-294. PubMed ID: 31267570
[TBL] [Abstract][Full Text] [Related]
16. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.
Desai RJ; Bateman BT; Huybrechts KF; Patorno E; Hernandez-Diaz S; Park Y; Dejene SZ; Cohen J; Mogun H; Kim SC
BMJ; 2017 Mar; 356():j895. PubMed ID: 28264814
[No Abstract] [Full Text] [Related]
17. Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors.
Hasikova L; Pavlikova M; Hulejova H; Kozlik P; Kalikova K; Mahajan A; Herrmann M; Stiburkova B; Zavada J
Rheumatol Int; 2019 Oct; 39(10):1749-1757. PubMed ID: 31363829
[TBL] [Abstract][Full Text] [Related]
18. The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?
Wroński J; Fiedor P
J Clin Pharmacol; 2019 Apr; 59(4):445-462. PubMed ID: 30476367
[TBL] [Abstract][Full Text] [Related]
19. Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis.
Wang JL; Yin WJ; Zhou LY; Zhou G; Liu K; Hu C; Zuo XC; Wang YF
Clin Rheumatol; 2020 Mar; 39(3):769-778. PubMed ID: 31823140
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?
Joyau C; Veyrac G; Dixneuf V; Jolliet P
Clin Exp Rheumatol; 2012; 30(5):700-6. PubMed ID: 22935567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
